Mingdao Lin

1838 North Guangzhou Ave
Guangzhou, 510515, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Correction: Identification of a metabolic-immune signature associated with prognosis in colon cancer and exploration of potential predictive efficacy of immunotherapy response.

Correction: Identification of a metabolic-immune signature associated with prognosis in colon cancer and exploration of potential predictive efficacy of immunotherapy response.

Journal: Clinical and experimental medicine

Published: June 11, 2025

HIF-PHIs associated with embolic and thrombotic events: a real-world pharmacovigilance study based on the Japan Adverse Drug Event Report database.

HIF-PHIs associated with embolic and thrombotic events: a real-world pharmacovigilance study based on the Japan Adverse Drug Event Report database.

Journal: Renal failure

Published: April 23, 2025

Acetylation-induced degradation of ECHS1 enhances BCAA accumulation and proliferation in KRAS-mutant colorectal cancer.

Acetylation-induced degradation of ECHS1 enhances BCAA accumulation and proliferation in KRAS-mutant colorectal cancer.

Journal: Journal of experimental & clinical cancer research : CR

Published: November 26, 2024

Identification of a metabolic-immune signature associated with prognosis in colon cancer and exploration of potential predictive efficacy of immunotherapy response.

Identification of a metabolic-immune signature associated with prognosis in colon cancer and exploration of potential predictive efficacy of immunotherapy response.

Journal: Clinical and experimental medicine

Published: August 02, 2024

Targeting ATM enhances radiation sensitivity of colorectal cancer by potentiating radiation-induced cell death and antitumor immunity.

Targeting ATM enhances radiation sensitivity of colorectal cancer by potentiating radiation-induced cell death and antitumor immunity.

Journal: Journal of advanced research

Published: June 01, 2024

KIAA1549 promotes the development and chemoresistance of colorectal cancer by upregulating ERCC2.

KIAA1549 promotes the development and chemoresistance of colorectal cancer by upregulating ERCC2.

Journal: Molecular and cellular biochemistry

Published: February 01, 2023

Targeting MS4A4A on tumour-associated macrophages restores CD8+ T-cell-mediated antitumour immunity.

Targeting MS4A4A on tumour-associated macrophages restores CD8+ T-cell-mediated antitumour immunity.

Journal: Gut

Published: November 28, 2022

GLUT5-KHK axis-mediated fructose metabolism drives proliferation and chemotherapy resistance of colorectal cancer.

GLUT5-KHK axis-mediated fructose metabolism drives proliferation and chemotherapy resistance of colorectal cancer.

Journal: Cancer letters

Published: October 05, 2021

S100P contributes to promoter demethylation and transcriptional activation of SLC2A5 to promote metastasis in colorectal cancer.

S100P contributes to promoter demethylation and transcriptional activation of SLC2A5 to promote metastasis in colorectal cancer.

Journal: British journal of cancer

Published: March 31, 2020

SNX16 activates c-Myc signaling by inhibiting ubiquitin-mediated proteasomal degradation of eEF1A2 in colorectal cancer development.

SNX16 activates c-Myc signaling by inhibiting ubiquitin-mediated proteasomal degradation of eEF1A2 in colorectal cancer development.

Journal: Molecular oncology

Published: September 22, 2019

POTEE drives colorectal cancer development via regulating SPHK1/p65 signaling.

POTEE drives colorectal cancer development via regulating SPHK1/p65 signaling.

Journal: Cell death & disease

Published: June 13, 2019

Showing 1-11 of 11

Last Updated: 09/26/2026